| 82 |
Ibuprofen
|
-
Ibuprofen, CAS-RN: 15687-27-1, DTXSID5020732
|
177: Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality
|
| 514 |
Hydroquinone
|
-
Hydroquinone, CAS-RN: 123-31-9, DTXSID7020716
|
296: Oxidative DNA damage leading to chromosomal aberrations and mutations
|
| 454 |
Hydrogen peroxide
|
-
Hydrogen peroxide, CAS-RN: 7722-84-1, DTXSID2020715
|
8 AOPs
|
| 132 |
Hydrocarbons, various
|
|
None
|
| 446 |
Hydralazine hydrochloride
|
-
Hydralazine hydrochloride, CAS-RN: 304-20-1, DTXSID1044645
|
2 AOPs
|
| 623 |
Hy
|
|
None
|
| 610 |
HMR3480
|
|
None
|
| 504 |
High LET Radiation
|
|
None
|
| 503 |
High LET Ra
|
|
None
|
| 646 |
high fat diet
|
|
403: combined unhealthy lifestyle factors leading to metabolic syndrome
|
| 500 |
High aspect ratio material
|
|
2 AOPs
|
| 150 |
Hexachlorobenzene
|
-
Hexachlorobenzene, CAS-RN: 118-74-1, DTXSID2020682
|
131: Aryl hydrocarbon receptor activation leading to uroporphyria
|
| 344 |
Heptachlor
|
-
Heptachlor, CAS-RN: 76-44-8, DTXSID3020679
|
10: Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain
|
| 299 |
Helicobacter pylori infection
|
|
229: Helicobacter pylori to gastric ulcer
|
| 276 |
Helicobacter pylori
|
|
217: Gastric ulcer formation
|
| 675 |
Heavy metals (cadmium, lead, copper, iron, nickel)
|
|
10 AOPs
|
| 620 |
HCoV-NL63
|
|
2 AOPs
|
| 351 |
Halothane
|
-
Halothane, CAS-RN: 151-67-7, DTXSID4025371
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 178 |
Haloperidol
|
-
Haloperidol, CAS-RN: 52-86-8, DTXSID4034150
|
2 AOPs
|
| 160 |
Halogenated phenols
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 788 |
Halogenated Hydrocarbons
|
|
519: Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality
|
| 239 |
Halofenozide
|
-
Halofenozide, CAS-RN: 112226-61-6, DTXSID4032619
|
2 AOPs
|
| 151 |
GW6471
|
|
6: Antagonist binding to PPARα leading to body-weight loss
|
| 255 |
Graphene oxide nanoparticles
|
|
2 AOPs
|
| 530 |
Gossypol
|
-
Gossypol, CAS-RN: 303-45-7, DTXSID5023110
|
154: Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
|